Rory Sheehan1,2, Amanda Sinai1, Nick Bass1, Pippa Blatchford3, Ingrid Bohnen4, Simon Bonell5, Ken Courtenay1,6, Angela Hassiotis1,2, Therese Markar7, Jane McCarthy8, Kamalika Mukherji7, Asim Naeem9, Dimitrios Paschos10, Natalia Perez-Achiaga3, Vijaya Sharma11, David Thomas12, Zuzana Walker1, Andre Strydom1,10. 1. Mental Health Sciences Unit, University College London, London, UK. 2. Camden Learning Disabilities Service, London, UK. 3. Royal Borough of Kensington and Chelsea Learning Disabilities Service, London, UK. 4. Central and North West London NHS Foundation Trust, Westminster Learning Disability Partnership, London, UK. 5. South London and Maudsley NHS Foundation Trust, Maudsley Hospital, London, UK. 6. Haringey Learning Disabilities Partnership, London, UK. 7. Hertfordshire Partnership University NHS Foundation Trust, Lister Hospital, Stevenage, UK. 8. Department of Forensic and Neurodevelopmental Sciences (FANS), Institute ofPsychiatry, London, UK. 9. Sutton and Merton Mental Health Learning Disability Team, Jubilee Health Centre East, Surrey, UK. 10. Islington Learning Disabilities Partnership, London, UK. 11. Hertfordshire Partnership University NHS Foundation Trust, Community Support Unit, Watford, UK. 12. Hackney Learning Disabilities Team, Hackney Service Centre, London, UK.
Abstract
OBJECTIVE: Dementia is a common clinical presentation among older adults with Down syndrome. The presentation of dementia in Down syndrome differs compared with typical Alzheimer's disease. The performance of manualised dementia criteria in the International Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) is uncertain in this population.We aimed to determine the concurrent validity and reliability of clinicians' diagnoses of dementia against ICD-10 and DSM-IV-TR diagnoses. Validity of clinical diagnoses were also explored by establishing the stability of diagnoses over time. METHODS: We used clinical data from memory assessments of 85 people with Down syndrome, of whom 64 (75.3%) had a diagnosis of dementia. The cases of dementia were presented to expert raters who rated the case as dementia or no dementia using ICD-10 and DSM-IV-TR criteria and their own clinical judgement. RESULTS: We found that clinician's judgement corresponded best with clinically diagnosed cases of dementia, identifying 84.4% cases of clinically diagnosed dementia at the time of diagnosis. ICD-10 criteria identified 70.3% cases, and DSM-IV-TR criteria identified 56.3% cases at the time of clinically diagnosed dementia. Over time, the proportion of cases meeting ICD-10 or DSM-IV-TR diagnoses increased, suggesting that experienced clinicians used their clinical knowledge of dementia presentation in Down syndrome to diagnose the disorder at an earlier stage than would have been possible had they relied on the classic description contained in the diagnostic systems. CONCLUSIONS: Clinical diagnosis of dementia in Down syndrome is valid and reliable and can be used as the standard against which new criteria such as the DSM-5 are measured.
OBJECTIVE:Dementia is a common clinical presentation among older adults with Down syndrome. The presentation of dementia in Down syndrome differs compared with typical Alzheimer's disease. The performance of manualised dementia criteria in the International Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) is uncertain in this population.We aimed to determine the concurrent validity and reliability of clinicians' diagnoses of dementia against ICD-10 and DSM-IV-TR diagnoses. Validity of clinical diagnoses were also explored by establishing the stability of diagnoses over time. METHODS: We used clinical data from memory assessments of 85 people with Down syndrome, of whom 64 (75.3%) had a diagnosis of dementia. The cases of dementia were presented to expert raters who rated the case as dementia or no dementia using ICD-10 and DSM-IV-TR criteria and their own clinical judgement. RESULTS: We found that clinician's judgement corresponded best with clinically diagnosed cases of dementia, identifying 84.4% cases of clinically diagnosed dementia at the time of diagnosis. ICD-10 criteria identified 70.3% cases, and DSM-IV-TR criteria identified 56.3% cases at the time of clinically diagnosed dementia. Over time, the proportion of cases meeting ICD-10 or DSM-IV-TR diagnoses increased, suggesting that experienced clinicians used their clinical knowledge of dementia presentation in Down syndrome to diagnose the disorder at an earlier stage than would have been possible had they relied on the classic description contained in the diagnostic systems. CONCLUSIONS: Clinical diagnosis of dementia in Down syndrome is valid and reliable and can be used as the standard against which new criteria such as the DSM-5 are measured.
Authors: J Tyrrell; M Cosgrave; M McCarron; J McPherson; J Calvert; A Kelly; M McLaughlin; M Gill; B A Lawlor Journal: Int J Geriatr Psychiatry Date: 2001-12 Impact factor: 3.485
Authors: Sarah L Ball; Anthony J Holland; Johnny Hon; Felicia A Huppert; Peter Treppner; Peter C Watson Journal: Int J Geriatr Psychiatry Date: 2006-07 Impact factor: 3.485
Authors: Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson Journal: Acta Neuropathol Date: 2019-02-07 Impact factor: 17.088
Authors: Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant Journal: Alzheimers Dement (Amst) Date: 2020-10-27
Authors: Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: Maureen B G Wissing; Aurora M Ulgiati; Johannes S M Hobbelen; Peter P De Deyn; Aly Waninge; Alain D Dekker Journal: J Appl Res Intellect Disabil Date: 2021-07-04
Authors: Sarah E Pape; Tamara Al Janabi; Nicholas J Ashton; Abdul Hye; Rory Sheehan; Paul Gallagher; Bernice Knight; Anne-Marije Prins; Ken Courtenay; Vesna Jordanova; Bini Thomas; Nagarajan Perumal; Craig Forbes; Angela Hassiotis; Andre Strydom Journal: Sci Rep Date: 2021-06-29 Impact factor: 4.379